SPRY4 is an inhibitor of the receptor-transduced mitogen-activated protein kinase (MAPK) signaling pathway. It is positioned upstream of RAS (HRAS) (MIM.190020) activation and impairs the formation of active GTP-RAS.
See also
SPRYs